Jean M. Franchi Gemini Therapeutics, Inc. (GMTX) insider trading activity

Jean M. Franchi is Chief Financial Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 63,499 shares of GMTX, which is worth approximately $1.55 Million. The most recent transaction as insider was on Jul 17, 2025, when has been sold 2,031 shares (Common Stock) at a price of $59.0 per share, resulting in proceeds of $119,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.5K

8.67% 3M change

73.18% 12M change

Total Value Held $1.55 Million

Jean M. Franchi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2025	SELL Open market or private sale	$119,829 $59.0 p/Share	2,031 Reduced 3.1%	63,499 Common Stock
Jul 10 2025	SELL Open market or private sale	$115,000 $57.5 p/Share	2,000 Reduced 2.96%	65,530 Common Stock
Jun 16 2025	SELL Open market or private sale	$104,520 $52.26 p/Share	2,000 Reduced 2.88%	67,530 Common Stock
Feb 18 2025	SELL Open market or private sale	$171,162 $54.58 p/Share	3,136 Reduced 4.32%	69,530 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	36,000 Added 33.13%	72,666 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	36,666 Added 50.0%	36,666 Common Stock

Also insider at

REPL

Replimune Group, Inc. Healthcare

Chief Financial Officer

BDSX

BIODESIX INC Healthcare

JMF

Jean M. Franchi

Chief Financial Officer

Woburn, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Value

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Gemini Therapeutics, Inc.

Track Activities on GMTX

Account